When a coronary stent cannot be placed, doctors turn to a range of alternatives, from specialized tools that modify the blockage to bypass surgery or long-term medication. Stent placement fails in roughly 3 to 5% of procedures, most often because the stent physically cannot reach the blocked section of the artery. The outcome depends heavily on why the stent failed and which backup options are available.
Why a Stent Sometimes Cannot Be Placed
The overwhelming majority of stent failures are delivery problems. In a large study of over 5,000 stent procedures, 3.3% of stents could not be deployed. Of those failures, 92% happened because the stent could not be threaded to the blockage site. The remaining 8% involved the stent failing to expand properly or slipping off the balloon catheter prematurely.
Several artery characteristics make delivery difficult. Heavy calcium buildup hardens the vessel wall so much that a balloon catheter cannot cross or inflate at the blockage. Extreme curves or tortuosity in the artery create angles the stent catheter cannot navigate. Chronic total occlusions, where an artery has been completely blocked for weeks or months, present the toughest challenge. Even at specialized centers, about 8 to 13% of chronic total occlusion procedures do not achieve full success, with older age, prior bypass surgery, and disease in multiple vessels all predicting a harder case.
In rare cases (about 0.3% of procedures), a stent can migrate loose inside a blood vessel, a complication called peripheral stent embolization that requires immediate retrieval.
Tools That Can Rescue a Failed Attempt
When calcium is the problem, interventional cardiologists have several devices that can modify the blockage so a stent can still go in during the same procedure.
Rotational atherectomy uses a tiny diamond-tipped burr that spins at high speed to grind through calcified plaque. It can be deployed as a planned first step for visibly calcified arteries or pulled in as a backup after a balloon fails to cross. Orbital atherectomy works on a similar principle, sanding down hard deposits from inside the vessel. Both approaches show comparable rates of complications at 30 days and one year.
A newer option, intravascular lithotripsy, sends sonic pressure waves through the artery wall to crack calcium deposits in place. It is the only technique that can fracture deep calcium that sits within the vessel wall rather than on its inner surface. After lithotripsy loosens the calcium, the artery becomes flexible enough for a balloon and stent to expand normally.
Cardiologists also use imaging tools inside the artery to troubleshoot a difficult case in real time. Intravascular ultrasound and optical coherence tomography give a cross-sectional view of the vessel wall, revealing exactly where calcium sits, how thick it is, and whether the artery has been inadvertently damaged. Procedures guided by these imaging tools result in fewer major cardiac events than those guided by standard X-ray angiography alone.
When Bypass Surgery Becomes the Next Step
If the blockage cannot be opened from inside the artery, coronary artery bypass grafting (CABG) reroutes blood flow around it using a vessel harvested from the chest or leg. This can happen on an elective, scheduled basis after a failed stent attempt, or it can be done as an emergency.
Emergency bypass surgery after a failed stent procedure is uncommon but serious. The most frequent reasons are extensive tearing (dissection) of the artery wall, which accounts for about 54% of emergency cases, followed by perforation of the vessel (20%) and repeated acute closure of the artery (20%). Emergency bypass carries a significantly higher risk than a planned operation. In one 10-year review of failed procedures, patients who went to emergency surgery had a 27% mortality rate within 30 days.
Elective bypass, by contrast, is a well-established operation with much lower risk. For patients with blockages in multiple arteries or in locations that are technically unfavorable for stenting, bypass often becomes the preferred long-term solution rather than a fallback.
Living on Medication Alone
In most cases where a stent fails and surgery is not immediately needed, the patient is managed with medications. In one study, 83% of patients with a failed stent procedure were treated conservatively with drugs rather than undergoing emergency surgery or a repeat procedure.
The standard medication approach for ongoing chest pain (angina) combines a beta-blocker or calcium channel blocker to slow the heart rate and reduce oxygen demand, along with a long-acting nitrate to widen blood vessels. When those first-line drugs are not enough, a medication called ranolazine can be added. It works differently from traditional heart drugs by altering how heart muscle cells handle sodium and calcium, reducing the stiffness that contributes to angina pain.
Medical management keeps many patients functional, but the long-term numbers are sobering. Among patients with blockages in multiple arteries who did not receive any form of revascularization, 11% died within one year and 37% within five years. Nearly two-thirds were rehospitalized for a cardiac problem within five years, and about one in four eventually underwent a delayed stent or bypass procedure anyway. These outcomes reflect a population with severe disease, so they represent a worst-case scenario rather than an average for all patients whose stent attempt was unsuccessful.
Non-Invasive Options for Refractory Symptoms
Some patients are not good candidates for either stenting or bypass surgery, whether because of anatomy, other health conditions, or prior procedures that limit what can be done. For these patients, a treatment called enhanced external counterpulsation (EECP) offers a completely non-invasive approach. Approved by the FDA in 1995, EECP uses inflatable cuffs wrapped around the legs that squeeze in rhythm with the heartbeat, pushing blood back toward the heart during the resting phase between beats. This encourages the growth of small collateral blood vessels that naturally bypass the blockage over time. Treatment typically involves 35 one-hour sessions over several weeks, done entirely as an outpatient.
What the Failure Rate Means for You
A failed stent attempt does not mean nothing can be done. The 5.4% failure rate reported in large studies reflects initial attempts. Many of those patients go on to have successful repeat procedures with specialized tools, planned bypass surgery, or effective symptom control with medications. The critical factor is what happens next. Patients who had a repeat catheter-based procedure after an initial failure had a 0% 30-day mortality rate in one series, compared with 16% for those managed conservatively and 27% for those needing emergency surgery.
If your cardiologist tells you a stent could not be placed, the conversation should focus on why it failed, whether a second attempt with different tools is realistic, and whether bypass surgery or optimized medication is the better path forward. The answer varies enormously depending on which artery is involved, how much calcium is present, how many vessels are affected, and your overall health.